Overall, clinical evidence supports its potential as a controlled research peptide for metabolic health studies, not as a therapeutic agent
Our MD specialists will discuss realistic outcomes based on your unique skin profile during your consultation at our Hyderabad clinic
Registration requires standard information including name, email, and shipping address
Serious Warnings According to safety information on the Direct Meds website, GLP-1 medications "may have serious side effects, including possible thyroid tumors
The decision to start Semaglutide GLP-1 therapy should be based on a personalized evaluation of each clients health, discussing potential risks and benefits
Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycaemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise